James E. Krause

Nessuna posizione attualmente

72 anni

Health Technology

Consumer Services

Profilo

James E.
Krause worked as the Director-Medical Scientist Training Program at Washington University in St. Louis from 1984 to 1997.
He then worked as the Senior Vice President-Biology at Neurogen Corp.
and as the Executive Vice President-Research & Development at ARMGO Pharma, Inc. Krause received his undergraduate and doctorate degrees from the University of Wisconsin.

Precedenti posizioni note di James E. Krause

Società	Posizione	Fine
Washington University in St. Louis	Corporate Officer/Principal	01/01/1997
ARMGO Pharma, Inc. ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.	Direttore Tecnico/Scientifico/R&S	-
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di James E. Krause

Formazione di James E. Krause

University of Wisconsin

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James E. Krause

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Health Technology
ARMGO Pharma, Inc. ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.	Health Technology